Coliprotec F4

RSS

porcine post-weaning diarrhoea vaccine (live)

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report. Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 29/06/2016

Authorisation details

Product details
Name
Coliprotec F4
Agency product number
EMEA/V/C/003797
Active substance
live non-pathogenic Escherichia coli O8:K87
International non-proprietary name (INN) or common name
porcine post-weaning diarrhoea vaccine (live)
Species
Pigs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI09AE03
Publication details
Marketing-authorisation holder
Prevtec Microbia GmbH
Revision
1
Date of issue of marketing authorisation valid throughout the European Union
16/03/2015
Contact address
Geyerspergerstrasse 27
80689 München
Germany

Product information

22/12/2015 Coliprotec F4 - EMEA/V/C/003797 - IB/0002

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Lyophilsate for suspension

Therapeutic indication

For active immunisation of pigs against enterotoxigenic F4-positive Escherichia coli in order to:

  • reduce the incidence of moderate to severe post-weaning Escherichia coli diarrhoea (PWD) in pigs;
  • reduce the colonisation of the ileum and faecal shedding of enterotoxigenic F4-positive Escherichia coli from infected pigs.

Assessment history

How useful was this page?

Add your rating